Dengue-Associated Acute Demyelinating Polyradiculoneuropathy: A Case Report.
Main Article Content
Abstract
Dengue is a viral disease endemic in tropical and subtropical regions. Four serotypes have been identified, with types 2 and 3 most frequently associated with neurological manifestations, including Guillain-Barré syndrome (GBS). A 51-year-old male patient with a history of dengue infection without severity criteria. He later develops asthenia, adynamia, and progressive weakness in the lower extremities, rapidly evolving into ascending paralysis and respiratory failure. He arrives at the emergency department with severe headache, nausea, and vomiting, presenting as hemodynamically stable but with progressive neurological deterioration.
A cranial CT scan shows no relevant findings. Neurology evaluates the patient, and immunoglobulin therapy is initiated due to suspected GBS. Laboratory tests reveal hyperglycemia (302 mg/dL) and mild hyponatremia (132 mmol/L), with a normal complete blood count and coagulation parameters. However, the patient’s condition deteriorates rapidly, leading to neurological decline and respiratory collapse. Despite therapeutic measures, the patient dies on the same day of admission. This case highlights the lethality of Guillain-Barré syndrome secondary to dengue and the importance of timely diagnosis and management. The rapid progression to respiratory failure and lack of response to treatment emphasize the need for a high index of suspicion and intensive monitoring in these patients.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Frantchez V, Fornelli R, Pérez Sartori G, Arteta Z, Cabrera S, Sosa L, et al. Dengue en adultos: diagnóstico, tratamiento y abordaje de situaciones especiales. Rev. Méd. Urug. [Internet]. 2016 Abr [citado 2025 Feb 12]; 32(1):43-51. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-03902016000100006&lng=es.
II. Vargas Navarro A, Bustos Vázquez E, Salas Casas A, Ruvalcaba Ledezma JC, Imbert Palafox JL. Infección por Dengue, un problema de salud pública en México. JONNPR. 2021;6(2):293-306. DOI: 10.19230/jonnpr.3771.
III. Dehesa López E, Gutiérrez Alatorre AF. Dengue: actualidades y características epidemiológicas en México. REVMEDUAS [Internet]. 2019 [citado el 2025 Feb 12];9(3):159. Disponible en: http://dx.doi.org/10.28960/revmeduas.2007-8013.v9.n3.006.
IV. Ledo-García D, González-Vargas PO, Salgado-Calderón I. Síndrome de Guillain-Barré: viejos y nuevos conceptos. Med Int Méx. 2018 Ene;34(1):72-81.
V. González M, Galvan M, Zabaleta O, Vargas P. Síndrome de Guillain Barré causado por el virus del dengue: a propósito de dos casos. Acta Neurol Colomb. [Internet]. 2015 Ene [citado 2025 Feb 12]; 31(1):54-59. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-87482015000100008&lng=en. DOI: 10.22379/242240228.
VI. Rebolledo-García D, González-Vargas PO, Salgado-Calderón I. Síndrome de Guillain-Barré: viejos y nuevos conceptos. Med Int Méx. 2018 Ene;34(1):72-81.
VII. González-Losada C, Lozano García M. Trastornos neurológicos asociados a la infección por virus dengue. Rev Cubana Med. 2020 Oct-Dic;59(4):e1162. Disponible en: https://orcid.org/0000-0002-7256-2649
VIII. Imtiaz H, Khan AF, Khan S. Dengue-induced Guillain–Barre syndrome: a case series. Egypt J Neurol Psychiatry Neurosurg. 2023;59(149). doi:10.1186/s41983-023-00741-4.
IX. Del Carpio-Orantes L. Síndrome de Guillain-Barré durante los brotes arbovirales en México. Med Int Méx. 2022;38(4):820-824. doi:10.24245/mim.v38i4.4429.
X. Aguirre-Chang G, Trujillo AN, Córdova JA, Segovia JL. Brote de síndrome de Guillain-Barré (SGB) asociado a brote de dengue y ambos precedidos por un incremento en las lluvias en zonas endémicas. ResearchGate Preprint. Octubre 2023. Disponible en: https://www.researchgate.net/publication/374696470.
XI. Ramírez-Rayón EM, Ávalos-Ríos JM, García-Jiménez FJ, Blancas-Cervantes JM. Síndrome de Guillain-Barré concomitante con infección por virus Zika. Med Int Méx. 2018;34(5):667-677. doi:10.24245/mim.v34i5.1778..